L’Oreal SA (OREP)

383.20
-1.80(-0.47%)
  • Volume:
    430
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    379.15 - 385.40
Earnings results expected in 13 days

L'Oreal will announce its quarterly financial results in 13 days. Traders should take this into account as the share price often fluctuates around this time period.

OREP Overview

Prev. Close
385
Day's Range
379.15-385.4
Revenue
18.37B
Open
385.4
52 wk Range
301-387.35
EPS
10
Volume
430
Market Cap
202.09B
Dividend (Yield)
4.80
(1.26%)
Average Volume (3m)
270
P/E Ratio
37.79
Beta
0.604
1-Year Change
2.83%
Shares Outstanding
535,186,562
Next Earnings Date
09 Feb 2023
What is your sentiment on L'Oreal?
or
Vote to see community's results!

L’Oreal SA News

L’Oreal SA Analysis

L’Oreal SA Company Profile

L’Oreal SA Company Profile

  • Type:Equity
  • Market:Germany
  • ISIN:FR0000120321
  • WKN:853888

L'Oreal SA is a France-based cosmetics company. The Company owns a wide range of brands organized into four division: Consumer Products, L’Oreal Luxe, Professionals Products and Active Cosmetics. They include L’Oreal Paris, Maybelline New York, Garnier, Lancme, Yves Saint Laurent, Giorgio Armani, Kiehl’s, Krastase, La Roche-Posay and SkinCeuticals, among others. It offers a wide range of products grouped into six business segments: Skincare, Makeup, Haircare, Hair Coloring, Fragrances and Other. Skincare offering includes facial skincare, face cleaners, body care and sun protection products. The Company owns stores and ecommerce websites. It is active globally.

Read More

Analyst Price Target

Average371.00 (-1.97% Downside)
High440.00
Low290.00
Price378.45
No. of Analysts24
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy
  • hi
    0
    • hi
      0
      • Network coverate slow moving. Effected. Vote bullish thanks you.
        0
        • Pretty anaemic growth and trading at 48 X earnings? 27 x EBITDA? 45 X (CFO-CFI) The numbers to make this valuation work just don't make sense. Not sure the P/E can expand much more unless there is a drop in earnings without a drop in the price. If earnings skyrocket due to inflation, then the discount rate needs to come up as well.
          0
          • Pretty anaemic growth and trading at 48 X earnings? 27 x EBITDA? 45 X (CFO-CFI) The numbers to make this valuation work just don't make sense. Not sure the P/E can expand much more unless there is a drop in earnings without a drop in the price. If earnings skyrocket due to inflation, then the discount rate needs to come up as well. But as usual, I'm probably wrong. Whatever makes sense nowadays has been flushed down the toilet.
            0
            • #boycott france
              6
              • #boycottfrenchproduct
                4
                • Long term gem
                  0